Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Apogee Therapeutics

Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
From Apogee Therapeutics
Via GlobeNewswire
Tickers APGE
Apogee Therapeutics Strengthens Team with Appointments of Industry Leaders to Board of Directors and Management
From Apogee Therapeutics
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS